6.
Kamronrithisorn T, Manonai J, Vallibhakara S, Sophonsritsuk A, Vallibhakara O
. Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause. Nutrients. 2020; 12(9).
PMC: 7551270.
DOI: 10.3390/nu12092876.
View
7.
Thurman A, Hull L, Stuckey B, Hatheway J, Mauck C, Zack N
. Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy. Climacteric. 2023; 26(5):479-488.
DOI: 10.1080/13697137.2023.2211763.
View
8.
Portman D, Gass M
. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014; 21(10):1063-8.
DOI: 10.1097/GME.0000000000000329.
View
9.
Fernandes M, de Mello Bianchi-Ferraro A, Sartori M, Di Bella Z, Cantarelli G, Dedonatto C
. CO 2 laser, radiofrequency, and promestriene in the treatment of genitourinary syndrome of menopause in breast cancer survivors: a histomorphometric evaluation of the vulvar vestibule. Menopause. 2023; 30(12):1213-1220.
DOI: 10.1097/GME.0000000000002274.
View
10.
Sarmento A, Fernandes F, Maia R, de Araujo Santos Camargo J, de Oliveira Crispim J, Eleuterio Junior J
. Microablative fractional radiofrequency for sexual dysfunction and vaginal Trophism: A randomized clinical trial. Clinics (Sao Paulo). 2023; 78:100293.
PMC: 10589764.
DOI: 10.1016/j.clinsp.2023.100293.
View
11.
Hofsjo A, Bohm-Starke N, Blomgren B, Jahren H, Steineck G, Bergmark K
. Radiotherapy-induced vaginal fibrosis in cervical cancer survivors. Acta Oncol. 2017; 56(5):661-666.
DOI: 10.1080/0284186X.2016.1275778.
View
12.
Salvatore S, Pitsouni E, Grigoriadis T, Zacharakis D, Pantaleo G, Candiani M
. CO laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial. Climacteric. 2020; 24(2):187-193.
DOI: 10.1080/13697137.2020.1829584.
View
13.
Palma F, Volpe A, Villa P, Cagnacci A
. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: The AGATA study. Maturitas. 2015; 83:40-4.
DOI: 10.1016/j.maturitas.2015.09.001.
View
14.
Bosak Z, Iravani M, Moghimipour E, Haghighizadeh M, Jelodarian P
. Effect of Chamomile Vaginal Gel on the Sexual Function in Postmenopausal Women: A Double-Blind Randomized Controlled Trial. J Sex Med. 2022; 19(6):983-994.
DOI: 10.1016/j.jsxm.2022.03.536.
View
15.
Meriggiola M, Villa P, Maffei S, Becorpi A, Di Paolantonio T, Nicolucci A
. Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy. Maturitas. 2024; 183:107950.
DOI: 10.1016/j.maturitas.2024.107950.
View
16.
Page A, Verbakel J, Verhaeghe J, Latul Y, Housmans S, Deprest J
. Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG. 2022; 130(3):312-319.
DOI: 10.1111/1471-0528.17335.
View
17.
Alvisi S, Gava G, Orsili I, Giacomelli G, Baldassarre M, Seracchioli R
. Vaginal Health in Menopausal Women. Medicina (Kaunas). 2019; 55(10).
PMC: 6843679.
DOI: 10.3390/medicina55100615.
View
18.
Veron L, Wehrer D, Annerose-Zephir G, Suciu V, Delaloge S, Pistilli B
. Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up. Breast Cancer Res Treat. 2021; 188(2):501-509.
PMC: 8062616.
DOI: 10.1007/s10549-021-06226-3.
View
19.
Cook E, Iglehart E, Baum G, Schover L, Newman L
. Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause. 2017; 24(12):1360-1364.
PMC: 5709152.
DOI: 10.1097/GME.0000000000000926.
View
20.
Santos L, Bonduki C, Dardes R, Heinke T, Patriarca M
. Effects of oxytocin versus promestriene on genitourinary syndrome: a pilot, prospective, randomized, double-blind study. Clinics (Sao Paulo). 2022; 77:100116.
PMC: 9531039.
DOI: 10.1016/j.clinsp.2022.100116.
View